These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36246837)

  • 1. Link between COVID-19 vaccines and myocardial infarction.
    Zafar U; Zafar H; Ahmed MS; Khattak M
    World J Clin Cases; 2022 Oct; 10(28):10109-10119. PubMed ID: 36246837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of in silico studies in the search for novel inhibitors against SARS-CoV-2.
    Ali F; Alom S; Shakya A; Ghosh SK; Singh UP; Bhat HR
    Arch Pharm (Weinheim); 2022 May; 355(5):e2100360. PubMed ID: 35244237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major severe acute respiratory coronavirus-2 (SARS-CoV-2) vaccine-associated adverse effects; benefits outweigh the risks.
    Esmaeilzadeh A; Maleki AJ; Moradi A; Siahmansouri A; Yavari MJ; Karami P; Elahi R
    Expert Rev Vaccines; 2022 Oct; 21(10):1377-1394. PubMed ID: 35986451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
    Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review.
    Caironi V; Pitoia F; Trimboli P
    Front Endocrinol (Lausanne); 2022; 13():900964. PubMed ID: 35813627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and reported adverse effects of coronavirus disease-2019 (COVID-19) vaccines in patients with rheumatic diseases.
    Aboud FM; Hussein RS; Hassan RM
    Egypt Rheumatol; 2023 Apr; 45(2):133-137. PubMed ID: 36597426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-Review Discussing the Reliability and Efficiency of COVID-19 Vaccines.
    Doroftei B; Ciobica A; Ilie OD; Maftei R; Ilea C
    Diagnostics (Basel); 2021 Mar; 11(4):. PubMed ID: 33804914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination is the most effective and best way to avoid the disease of COVID-19.
    Lotfi H; Mazar MG; Ei NMH; Fahim M; Yazdi NS
    Immun Inflamm Dis; 2023 Aug; 11(8):e946. PubMed ID: 37647441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?
    Houshmand B; Keyhan SO; Fallahi HR; Ramezanzade S; Sadeghi E; Yousefi P
    Maxillofac Plast Reconstr Surg; 2022 Jan; 44(1):3. PubMed ID: 35025010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa).
    Ben Ahmed M; Bellali H; Gdoura M; Zamali I; Kallala O; Ben Hmid A; Hamdi W; Ayari H; Fares H; Mechri K; Marzouki S; Triki H; Ben Alaya N; Chahed MK; Klouz A; Sebai Ben Amor S; Ben Rayana C; Razgallah Khrouf M; Hamouda C; Elkadri N; Daghfous R; Trabelsi A
    Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 35893838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Landscape review of active vaccine safety surveillance activities for COVID-19 vaccines globally.
    ShamaeiZadeh PA; Jaimes CV; Knoll MD; Espié E; Chandler RE
    Vaccine X; 2024 Jun; 18():100485. PubMed ID: 38655548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Homologous and Heterologous Vaccine Boosters With SARS-CoV-2 Infection in BBIBP-CorV Vaccinated Healthcare Personnel.
    Park S; Gatchalian KK; Oh H
    Cureus; 2022 Jul; 14(7):e27323. PubMed ID: 36043010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Personalized predictions of adverse side effects of the COVID-19 vaccines.
    Jamshidi E; Asgary A; Kharrazi AY; Tavakoli N; Zali A; Mehrazi M; Jamshidi M; Farrokhi B; Maher A; von Garnier C; Rahi SJ; Mansouri N
    Heliyon; 2023 Jan; 9(1):e12753. PubMed ID: 36597482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Complications of SARS-CoV-2 Vaccines: An Overview.
    Shiravi AA; Ardekani A; Sheikhbahaei E; Heshmat-Ghahdarijani K
    Cardiol Ther; 2022 Mar; 11(1):13-21. PubMed ID: 34845662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of budgetary impact of COVID-19 vaccination in Latin AmericaAnálise do impacto orçamentário da vacinação contra a COVID-19 na América Latina].
    Taborda AR; Murillo DA; Moreno CL; Taborda PAR; Fuquen M; Díaz PA; Londoño D
    Rev Panam Salud Publica; 2022; 46():e5. PubMed ID: 35350457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands.
    Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ
    EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and T Cell Responses against SARS-CoV-2 Elicited by the Third Dose of BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) Vaccines Using a Homologous or Heterologous Booster Vaccination Strategy.
    Matula Z; Gönczi M; Bekő G; Kádár B; Ajzner É; Uher F; Vályi-Nagy I
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.